The use of infliximab therapeutic drug monitoring in virtual biologics clinic for inflammatory bowel disease (IBD) leads to clinically durable results

被引：0
|
作者：
Sagar, R. [1 ]
Lenti, M. [1 ]
Clark, T. [1 ]
Rafferty, H. [1 ]
Gracie, D. [1 ]
Ford, A. [1 ]
O'Connor, A. [1 ]
Hamlin, J. [1 ]
Ahmad, T. [2 ]
Selinger, C. [1 ]
机构：
[1] St James Univ Hosp, Gastroenterol, Leeds, W Yorkshire, England
[2] Royal Devon & Exeter Fdn Trust, Gastroenterol, Exeter, Devon, England
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P737
引用
收藏
页码：S484 / S485
页数：3
相关论文
共 50 条
  • [21] THE IMPACT OF THERAPEUTIC DRUG MONITORING DURING BIOSIMILAR INFLIXIMAB SWITCH IN INFLAMMATORY BOWEL DISEASE
    Ranjan, Ravi
    Myers, Sally
    Crissop, Linda
    Ritchie, Susan
    Maw, Frances
    Sebastian, Shaji
    Dhar, Anjan
    GUT, 2018, 67 : A74 - A74
  • [22] The impact of therapeutic drug monitoring during biosimilar infliximab switch in inflammatory bowel disease
    Ranjan, R.
    Myers, S.
    Crissop, L.
    Ritchie, S.
    Maw, F.
    Sebastian, S.
    Dhar, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S335 - S335
  • [23] Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
    Kolho, Kaija-Leena
    FRONTIERS IN PEDIATRICS, 2021, 8
  • [24] Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
    Paul, Stephane
    Del Tedesco, Emilie
    Marotte, Hubert
    Clavel, Lea
    Phelip, Jean Marc
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    GASTROENTEROLOGY, 2013, 144 (05) : S92 - S92
  • [25] Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 369 - 370
  • [26] Thiopurine Use and Persistence on Infliximab Therapy for Inflammatory Bowel Disease (IBD)
    Haynes, Kevin
    Curtis, Jeffery R.
    Chen, Lang
    Osterman, Mark T.
    Saag, Ken G.
    Lewis, James D.
    GASTROENTEROLOGY, 2011, 140 (05) : S781 - S781
  • [27] Thiopurine Use and Persistence on Infliximab Therapy for Inflammatory Bowel Disease (IBD)
    Haynes, Kevin
    Lewis, James D.
    Osterman, Mark T.
    Chen, Lang
    Kenneth, Saag
    Curtis, Jeffery R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S71 - S71
  • [28] Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease
    Quera, Rodrigo
    Moreno, Mauricio
    Simian, Daniela
    Ibanez, Patricio
    Lubascher, Jaime
    Figueroa, Carolina
    Flores, Lilian
    Kronberg, Udo
    Pizarro, Gonzalo
    Fluxa, Daniela
    REVISTA MEDICA DE CHILE, 2018, 146 (11) : 1241 - 1251
  • [29] Therapeutic drug monitoring in inflammatory bowel disease
    Kopylov, Uri
    Ben-Horin, Shomron
    Seidman, Ernest
    ANNALS OF GASTROENTEROLOGY, 2014, 27 (04): : 304 - 312
  • [30] Therapeutic drug monitoring in inflammatory bowel disease
    Jossen, Jacqueline
    Dubinsky, Marla
    CURRENT OPINION IN PEDIATRICS, 2016, 28 (05) : 620 - 625
12345